| Literature DB >> 26636088 |
Benjamin D Kuhns1, Alexander E Weber1, David M Levy1, Thomas H Wuerz2.
Abstract
Femoroacetabular impingement (FAI) is a clinical syndrome resulting from abnormal hip joint morphology and is a common cause of hip pain in young adults. FAI has been posited as a precursor to hip osteoarthritis (OA); however, conflicting evidence exists and the true natural history of the disease is unclear. The purpose of this article is to review the current understanding of how FAI damages the hip joint by highlighting its pathomechanics and etiology. We then review the current evidence relating FAI to OA. Lastly, we will discuss the potential of hip preservation surgery to alter the natural history of FAI, reduce the risk of developing OA and the need for future arthroplasty.Entities:
Keywords: FAI etiology; femoroacetabular impingement; hip arthroscopy; hip osteoarthritis; hip preservation surgery
Year: 2015 PMID: 26636088 PMCID: PMC4644807 DOI: 10.3389/fsurg.2015.00058
Source DB: PubMed Journal: Front Surg ISSN: 2296-875X
Figure 1Three-dimensional CT reconstructions demonstrating cam (A) and pincer (B) deformities.
General characteristics of cam and pincer deformities in FAI.
| Cam | Pincer | |
|---|---|---|
| Presentation | Hip/groin pain | Hip/groin pain |
| Demographic trends | Younger males | Young–middle-aged females |
| Osseus morphology | Aspherical bump at the femoral head–neck junction, decreased femoral head–neck offset | Focal or global acetabular overcoverage; acetabular retroversion |
| Injury mechanism | Primarily affects cartilage with repeated flexion. The labrum gets damaged secondarily | Affects labrum primarily; with damage patterns located on the peripheral acetabulum. Associated with contrecoup lesions |
| Radiographic predictors | Pistol grip deformity; alpha angle >50° | LCEA > 39°; ACEA > 39°, posterior wall sign |
Molecular biomarkers associated with the onset and/or progression of hip osteoarthritis and their relation to FAI.
| Biomarker | Relation to hip OA | Relation to FAI |
|---|---|---|
| Cartilage oligomeric protein (COMP) ( | Higher levels may be associated with hip OA progression | Elevated in male athletes with FAI (1 study) |
| 25-OH vitamin D ( | Lower levels may be associated with worsening Hip OA | |
| N-terminal telopeptide (NTX) ( | Higher levels may be associated with hip OA progression | |
| Urine type II collagen C telopeptide (CTX-II) ( | Higher levels associated with hip OA progression | |
| Tissue inhibitor of metalloproteinase-1 (TIMP) ( | Higher levels may be associated with hip OA progression | |
| Vascular cell adhesion molecule 1 (VCAM-1) ( | Higher levels may be associated with hip OA progression | |
| C-reactive protein (CRP) ( | Higher in FAI patients compared to non-FAI patients (1 study) | |
| Synovial fibronectin-aggrecan complex(sf-FAC) ( | Higher in patients undergoing surgery for hip replacement compared to hip arthroscopy (1 study) |